Administration of Memantine During Withdrawal Mitigates Overactivity and Spatial Learning Impairments Associated with Neonatal Alcohol Exposure in Rats

Alcoholism: Clinical and Experimental Research

Volumn 38, Issue 2, 2014, Pages 529-537

  Idrus, Nirelia M ^a   Mcgough, Nancy N H ^a   Riley, Edward P ^a   Thomas, Jennifer D ^a  

^a SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

Binge Ethanol; Excitotoxicity; Fetal Alcohol; NMDA; Treatment

Indexed keywords

ALCOHOL; DIZOCILPINE; ELIPRODIL; MALTOSE; MEMANTINE;

ALCOHOL WITHDRAWAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; EXPOSURE; FEMALE; INTUBATION; LEARNING DISORDER; LOCOMOTION; MALE; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; REARING; SPATIAL DISCRIMINATION; SPATIAL LEARNING;

ANIMALIA; RATTUS;

BINGE ETHANOL; EXCITOTOXICITY; FETAL ALCOHOL; NMDA; TREATMENT;

ALCOHOL WITHDRAWAL DELIRIUM; ANIMALS; ANIMALS, NEWBORN; BINGE DRINKING; CELL COUNT; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DISCRIMINATION LEARNING; ETHANOL; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GROWTH; HYPERKINESIS; LEARNING DISORDERS; MALE; MAZE LEARNING; MEMANTINE; MOTOR ACTIVITY; PSYCHOMOTOR PERFORMANCE; PURKINJE CELLS; RATS; RATS, SPRAGUE-DAWLEY; REVERSAL LEARNING;

EID: 84893709989     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/acer.12259     Document Type: Article

References (55)

1. Allgaier C (2002) Ethanol sensitivity of NMDA receptors. Neurochem Int 41:377-382.
2. Arndt MA, Battaglia V, Parisi E, Lortie MJ, Isome M, Baskerville C, Pizzo DP, Ientile R, Colombatto S, Toninello A, Satriano J (2009) The arginine metabolite agmatine protects mitochondrial function and confers resistance to cellular apoptosis. Am J Physiol Cell Physiol 296:C1411-C1419.
3. Bardgett ME, Griffith MS, Foltz RF, Hopkins JA, Massie CM, O'Connell SM (2006) The effects of clozapine on delayed spatial alternation deficits in rats with hippocampal damage. Neurobiol Learn Mem 85:86-94.
4. Beconi MG, Howland D, Park L, Lyons K, Giuliano J, Dominguez C, Munoz-Sanjuan I, Pacifici R (2011) Pharmacokinetics of memantine in rats and mice. PLoS Curr 3:RRN1291.
5. Bonthius DJ, West JR (1990) Alcohol-induced neuronal loss in developing rats: increased brain damage with binge exposure. Alcohol Clin Exp Res 14:107-118.
6. Costa ET, Savage DD, Valenzuela CF (2000) A review of the effects of prenatal or early postnatal ethanol exposure on brain ligand-gated ion channels. Alcohol Clin Exp Res 24:706-715.
7. Dobbing J, Sands J (1979) Comparative aspects of the brain growth spurt. Early Hum Dev 3:79-83.
8. Godsil BP, Stefanacci L, Fanselow MS (2005) Bright light suppresses hyperactivity induced by excitotoxic dorsal hippocampus lesions in the rat. Behav Neurosci 119:1339-1352.
9. Goodlett CR, Johnson TB (1997) Neonatal binge ethanol exposure using intubation: timing and dose effects on place learning. Neurotoxicol Teratol 19:435-446.
10. Hoffman PL, Tabakoff B (1994) The role of the NMDA receptor in ethanol withdrawal. EXS 71:61-70.
11. Hong S, Lee JE, Kim CY, Seong GJ (2007) Agmatine protects retinal ganglion cells from hypoxia-induced apoptosis in transformed rat retinal ganglion cell line. BMC Neurosci 8:81.
12. Honse Y, Randall PK, Leslie SW (2003) Prenatal ethanol exposure modifies [3H]MK-801 binding to NMDA receptors: spermidine and ifenprodil. Alcohol Clin Exp Res 27:1993-2001.
13. Hoyer D, Hannon JP, Martin GR (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71:533-554.
14. Idrus NM, McGough NN, Riley EP, Thomas JD (2011a) Administration of memantine during ethanol withdrawal in neonatal rats: effects on long-term ethanol-induced motor incoordination and cerebellar Purkinje cell loss. Alcohol Clin Exp Res 35:355-364.
15. Idrus NM, McGough NN, Spinetta MJ, Thomas JD, Riley EP (2011b) The effects of a single memantine treatment on behavioral alterations associated with binge alcohol exposure in neonatal rats. Neurotoxicol Teratol 33:444-450.
16. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, Dikranian K, Tenkova TI, Stefovska V, Turski L, Olney JW (1999) Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283:70-74.
17. Ikonomidou C, Mosinger JL, Salles KS, Labruyere J, Olney JW (1989) Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N-methyl-aspartate neurotoxicity. J Neurosci 9:2809-2818.
18. Ikonomidou C, Turski L (2002) Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol 1:383-386.
19. Keynan O, Mirovsky Y, Dekel S, Gilad VH, Gilad GM (2010) Safety and efficacy of dietary agmatine sulfate in lumbar disc-associated radiculopathy. An open-label, dose-escalating study followed by a randomized, double-blind, placebo-controlled trial. Pain Med 11:356-368.
20. Lacroix L, White I, Feldon J (2002) Effect of excitotoxic lesions of rat medial prefrontal cortex on spatial memory. Behav Brain Res 133:69-81.
21. Lewis B, Wellmann KA, Barron S (2007) Agmatine reduces balance deficits in a rat model of third trimester binge-like ethanol exposure. Pharmacol Biochem Behav 88:114-121.
22. Livy DJ, Miller EK, Maier SE, West JR (2003) Fetal alcohol exposure and temporal vulnerability: effects of binge-like alcohol exposure on the developing rat hippocampus. Neurotoxicol Teratol 25:447-458.
23. Lukoyanov NV, Paula-Barbosa MM (2001) Memantine, but not dizocilpine, ameliorates cognitive deficits in adult rats withdrawn from chronic ingestion of alcohol. Neurosci Lett 309:45-48.
24. Manning SM, Talos DM, Zhou C, Selip DB, Park HK, Park CJ, Volpe JJ, Jensen FE (2008) NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia. J Neurosci 28:6670-6678.
25. Melendez RI, Hicks MP, Cagle SS, Kalivas PW (2005) Ethanol exposure decreases glutamate uptake in the nucleus accumbens. Alcohol Clin Exp Res 29:326-333.
26. Muhonen LH, Lahti J, Sinclair D, Lonnqvist J, Alho H (2008) Treatment of alcohol dependence in patients with co-morbid major depressive disorder-predictors for the outcomes with memantine and escitalopram medication. Subst Abuse Treat Prev Policy 3:20.
27. Nixon K, Hughes PD, Amsel A, Leslie SW (2004) NMDA receptor subunit expression after combined prenatal and postnatal exposure to ethanol. Alcohol Clin Exp Res 28:105-112.
28. O'Leary-Moore SK, Parnell SE, Lipinski RJ, Sulik KK (2011) Magnetic resonance-based imaging in animal models of fetal alcohol spectrum disorder. Neuropsychol Rev 21:167-185.
29. Parsons CG, Gruner R, Rozental J, Millar J, Lodge D (1993) Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3, 5-dimethyladamantan). Neuropharmacology 32:1337-1350.
30. Parsons CG, Stoffler A, Danysz W (2007) Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system-too little activation is bad, too much is even worse. Neuropharmacology 53:699-723.
31. Rammes G, Danysz W, Parsons CG (2008) Pharmacodynamics of memantine: an update. Curr Neuropharmacol 6:55-78.
32. Rao VL, Dogan A, Todd KG, Bowen KK, Dempsey RJ (2001) Neuroprotection by memantine, a non-competitive NMDA receptor antagonist after traumatic brain injury in rats. Brain Res 911:96-100.
33. Rasmussen SA, Erickson JD, Reef SE, Ross DS (2009) Teratology: from science to birth defects prevention. Birth Defects Res A Clin Mol Teratol 85:82-92.
34. Riley EP, Barron S, Driscoll CD, Hamlin RT (1986) The effects of physostigmine on open-field behavior in rats exposed to alcohol prenatally. Alcohol Clin Exp Res 10:50-53.
35. Riley EP, McGee CL (2005) Fetal alcohol spectrum disorders: an overview with emphasis on changes in brain and behavior. Exp Biol Med (Maywood) 230:357-365.
36. Rogawski MA, Wasterlain CG, Mazarati AM (2000) Re: Mazarati et al. "..clinically available [antiepileptic drug] with a moderate affinity for the glycine site of the N-methyl-D-aspartate (NMDA) receptor". Epilepsia 41:918-919.
37. Sanger DJ (1992) NMDA antagonists disrupt timing behaviour in rats. Behav Pharmacol 3:593-600.
38. Schneider ML, Moore CF, Adkins MM (2011) The effects of prenatal alcohol exposure on behavior: rodent and primate studies. Neuropsychol Rev 21:186-203.
39. Shah RS, Lee HG, Xiongwei Z, Perry G, Smith MA, Castellani RJ (2008) Current approaches in the treatment of Alzheimer's disease. Biomed Pharmacother 62:199-207.
40. Shopsin B (in press) The clinical antidepressant effect of exogenous agmatine is not reversed by parachlorophenylalanine: a pilot study. Acta Neuropsychiatr [Epub ahead of print].
41. Spear-Smith J, Brien JF, Grafe M, Allrich R, Reynolds JD (2000) Chronic ethanol exposure during late gestation produces behavioral anomalies in neonatal lambs. Neurotoxicol Teratol 22:205-212.
42. Stepanyan TD, Farook JM, Kowalski A, Kaplan E, Barron S, Littleton JM (2008) Alcohol withdrawal-induced hippocampal neurotoxicity in vitro and seizures in vivo are both reduced by memantine. Alcohol Clin Exp Res 32:2128-2135.
43. Svensson TH (2000) Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs. Brain Res Brain Res Rev 31:320-329.
44. Tajuddin NF, Druse MJ (2001) A persistent deficit of serotonin neurons in the offspring of ethanol-fed dams: protective effects of maternal ipsapirone treatment. Brain Res Dev Brain Res 129:181-188.
45. Thomas JD, Edwards RB, Chen W-JA (2002a) MK-801 administration during withdrawal attenuates hippocampal CA1 pyramidal cell loss in rats neonatally exposed to alcohol. Alcohol 26:134A.
46. Thomas JD, Fleming SL, Riley EP (2001) MK-801 can exacerbate or attenuate behavioral alterations associated with neonatal alcohol exposure in the rat, depending on the timing of administration. Alcohol Clin Exp Res 25:764-773.
47. Thomas JD, Fleming SL, Riley EP (2002b) Administration of low doses of MK-801 during ethanol withdrawal in the developing rat pup attenuates alcohol's teratogenic effects. Alcohol Clin Exp Res 26:1307-1313.
48. Thomas JD, Garcia GG, Dominguez HD, Riley EP (2004) Administration of eliprodil during ethanol withdrawal in the neonatal rat attenuates ethanol-induced learning deficits. Psychopharmacology 175:189-195.
49. Thomas JD, Weinert SP, Sharif S, Riley EP (1997) MK-801 administration during ethanol withdrawal in neonatal rat pups attenuates ethanol-induced behavioral deficits. Alcohol Clin Exp Res 21:1218-1225.
50. Tsai G, Coyle JT (1998) The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu Rev Med 49:173-184.
51. Wedzony K, Mackowiak M, Zajaczkowski W, Fijal K, Chocyk A, Czyrak A (2000) WAY 100135, an antagonist of 5-HT1A serotonin receptors, attenuates psychotomimetic effects of MK-801. Neuropsychopharmacology 23:547-559.
52. Wesemann W, Schollmeyer JD, Sturm G (1982) Distribution of memantine in brain, liver, and blood of the rat. Arzneimittelforschung 32:1243-1245.
53. West JR, Goodlett CR, Bonthius DJ, Hamre KM, Marcussen BL (1990) Cell population depletion associated with fetal alcohol brain damage: mechanisms of BAC-dependent cell loss. Alcohol Clin Exp Res 14:813-818.
54. Yang Z, Zhou X, Zhang Q (2013) Effectiveness and safety of memantine treatment for Alzheimer's disease. J Alzheimers Dis 36:445-458.
55. Zhu MY, Wang WP, Bissette G (2006) Neuroprotective effects of agmatine against cell damage caused by glucocorticoids in cultured rat hippocampal neurons. Neuroscience 141:2019-2027.